Tyr783
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr783  -  ITGB1 (human)

Site Information
DtGENPIyksAVttV   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 447710
Available spectra:  1 CST
Associated spectra:  7 CST

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 3 , 20 ) , mass spectrometry ( 1 , 2 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 16 , 17 , 18 , 19 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 205 , 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 214 , 215 , 216 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 226 , 227 , 228 , 229 , 230 , 231 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 , 299 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 318 , 319 , 320 , 321 , 322 , 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 336 , 337 , 338 , 339 , 340 , 341 , 342 , 343 , 344 , 345 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 448 , 449 , 450 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 , 479 , 480 , 481 , 482 , 483 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 515 , 516 , 517 , 518 , 519 , 520 , 521 , 522 , 523 , 524 , 525 , 526 , 527 , 528 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 545 , 546 , 547 , 548 , 549 , 550 , 551 , 552 , 553 , 554 , 555 , 556 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 567 , 568 , 569 , 570 , 571 , 572 , 573 , 574 , 575 , 576 , 577 , 578 , 579 , 580 , 581 , 582 , 583 , 584 , 585 , 586 , 587 , 588 , 589 , 590 , 591 , 592 , 593 , 594 , 595 , 596 , 597 , 598 , 599 , 600 , 601 , 602 , 603 , 604 , 605 , 606 , 607 , 608 , 609 , 610 , 611 , 612 , 613 , 614 , 615 , 616 , 617 , 618 , 619 , 620 , 621 , 622 , 623 , 624 , 625 , 626 , 627 , 628 , 629 , 630 , 631 , 632 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 640 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 667 , 668 , 669 , 670 , 671 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 679 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 708 , 709 , 710 , 711 , 712 , 713 , 714 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 736 , 737 , 738 , 739 , 740 , 741 , 742 , 743 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 783 , 784 , 785 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 793 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 802 , 803 , 804 , 805 , 806 , 807 , 808 , 809 , 810 , 811 , 812 , 813 , 814 , 815 , 816 , 817 , 818 , 819 , 820 , 821 , 822 , 823 , 824 , 825 , 826 , 827 , 828 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 837 , 838 , 839 , 840 , 841 , 842 , 843 , 844 , 845 , 846 , 847 , 848 , 849 , 850 , 851 , 852 , 853 , 854 , 855 , 856 , 857 , 858 , 859 , 860 , 861 , 862 , 863 , 864 , 865 , 866 , 867 , 868 , 869 , 870 , 871 , 872 , 873 , 874 , 875 , 876 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 903 , 904 , 905 , 906 , 907 , 908 , 909 , 910 , 911 , 912 , 913 , 914 , 915 , 916 , 917 , 918 , 919 , 920 , 921 , 922 , 923 , 924 , 925 , 926 , 927 , 928 , 929 , 930 , 931 , 932 , 933 , 934 , 935 , 936 , 937 , 938 , 939 , 940 , 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 959 , 960 , 961 , 962 , 963 , 964 , 965 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 993 , 994 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1003 , 1004 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1011 , 1012 , 1013 , 1014 , 1015 , 1016 , 1017 , 1018 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 , 1027 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1034 , 1035 , 1036 , 1037 , 1038 , 1039 , 1040 , 1041 , 1042 , 1043 , 1044 , 1045 , 1046 , 1047 , 1048 , 1049 , 1050 , 1051 , 1052 , 1053 , 1054 , 1055 , 1056 , 1057 , 1058 , 1059 , 1060 , 1061 , 1062 , 1063 , 1064 , 1065 , 1066 , 1067 , 1068 , 1069 , 1070 , 1071 , 1072 , 1073 , 1074 , 1075 , 1076 , 1077 , 1078 , 1079 , 1080 , 1081 , 1082 , 1083 , 1084 , 1085 , 1086 , 1087 , 1088 , 1089 , 1090 , 1091 , 1092 , 1093 , 1094 , 1095 , 1096 , 1097 , 1098 , 1099 , 1100 , 1101 , 1102 , 1103 , 1104 , 1105 , 1106 , 1107 , 1108 , 1109 , 1110 , 1111 , 1112 , 1113 , 1114 , 1115 , 1116 , 1117 , 1118 , 1119 , 1120 , 1121 , 1122 , 1123 , 1124 , 1125 , 1126 , 1127 , 1128 , 1129 , 1130 , 1131 , 1132 , 1133 , 1134 , 1135 , 1136 , 1137 , 1138 , 1139 , 1140 , 1141 , 1142 , 1143 , 1144 , 1145 , 1146 , 1147 , 1148 ) , mutation of modification site ( 3 , 225 , 782 ) , phospho-antibody ( 3 , 20 ) , western blotting ( 3 , 20 )
Disease tissue studied:
adenoid cystic carcinoma ( 621 , 623 ) , bile-duct cancer ( 69 , 70 , 71 , 589 , 590 , 615 ) , bladder cancer ( 293 , 876 , 878 , 913 ) , bone cancer ( 25 , 745 , 746 , 771 , 772 , 773 , 1122 ) , Ewing's sarcoma ( 25 , 771 ) , osteosarcoma ( 25 , 745 , 746 , 772 , 773 , 1122 ) , brain cancer ( 19 , 157 , 158 , 166 , 188 , 422 , 423 , 424 , 425 , 426 , 427 , 652 , 783 , 785 , 786 , 885 , 931 , 932 , 1007 , 1008 , 1016 , 1018 , 1021 , 1022 , 1023 , 1028 , 1038 , 1045 , 1109 ) , astrocytoma ( 157 , 158 , 166 , 652 , 932 , 1028 , 1038 , 1109 ) , glioblastoma ( 188 , 422 , 423 , 424 , 425 , 426 , 427 , 885 , 931 , 1007 , 1008 , 1016 , 1018 , 1022 , 1023 , 1045 ) , glioblastoma multiforme ( 19 , 783 , 785 , 786 , 931 , 1016 , 1018 , 1045 ) , glioma ( 19 , 188 , 422 , 423 , 424 , 425 , 426 , 427 , 783 , 785 , 786 , 885 , 931 , 1007 , 1008 , 1016 , 1018 , 1022 , 1023 , 1045 ) , breast cancer ( 13 , 526 , 527 , 787 , 788 , 789 , 790 , 791 , 792 , 873 , 893 , 894 , 910 , 911 , 914 , 937 , 938 , 948 , 951 , 1031 , 1039 , 1048 , 1086 , 1087 , 1089 , 1129 , 1130 ) , breast adenocarcinoma ( 910 , 951 , 1089 ) , breast ductal carcinoma ( 1031 , 1039 ) , luminal A breast cancer ( 1 ) , luminal B breast cancer ( 1 ) , breast cancer, triple negative ( 1 , 893 , 894 , 1039 , 1048 ) , cervical cancer ( 380 ) , cervical adenocarcinoma ( 380 ) , colorectal cancer ( 20 , 25 , 82 , 83 , 84 , 149 , 153 , 154 , 201 , 204 , 230 , 294 , 295 , 740 , 741 , 742 , 743 , 777 , 778 , 845 , 861 , 919 , 954 , 967 , 999 , 1014 , 1015 , 1042 , 1069 , 1070 , 1073 , 1107 , 1108 , 1111 , 1112 , 1137 , 1138 , 1139 ) , colorectal carcinoma ( 20 , 25 , 82 , 83 , 84 , 153 , 154 , 294 , 295 , 740 , 741 , 742 , 743 , 777 , 778 , 845 , 861 , 919 , 954 , 967 , 999 , 1014 , 1015 , 1042 , 1069 , 1070 , 1073 , 1107 , 1108 , 1111 , 1112 , 1137 , 1138 , 1139 ) , colorectal cancer, surrounding tissue ( 203 ) , esophageal cancer ( 67 , 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 331 , 533 , 534 , 535 , 536 , 538 , 539 , 540 , 541 , 542 , 904 , 927 , 998 , 1009 , 1010 ) , esophageal carcinoma ( 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 904 , 1009 , 1010 ) , esophageal cancer, surrounding tissue ( 537 ) , gallbladder cancer ( 614 , 654 ) , gallbladder carcinoma ( 654 ) , gastric cancer ( 20 , 22 , 29 , 31 , 32 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 59 , 60 , 61 , 62 , 81 , 101 , 102 , 103 , 104 , 110 , 111 , 112 , 113 , 114 , 115 , 141 , 142 , 143 , 144 , 145 , 146 , 155 , 156 , 164 , 165 , 238 , 243 , 252 , 261 , 262 , 271 , 272 , 273 , 274 , 283 , 284 , 285 , 353 , 354 , 356 , 366 , 381 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 445 , 446 , 549 , 550 , 551 , 552 , 553 , 554 , 634 , 635 , 636 , 638 , 643 , 644 , 645 , 648 , 712 , 714 , 716 , 717 , 720 , 721 , 722 , 723 , 724 , 725 , 729 , 730 , 731 , 734 , 839 , 840 , 843 , 844 , 900 , 901 , 963 , 964 , 965 , 966 , 968 ) , gastric carcinoma ( 20 , 29 , 31 , 32 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 59 , 60 , 61 , 62 , 81 , 101 , 102 , 103 , 104 , 110 , 111 , 112 , 113 , 114 , 115 , 141 , 142 , 143 , 144 , 145 , 146 , 155 , 156 , 164 , 165 , 238 , 243 , 252 , 261 , 262 , 271 , 272 , 273 , 274 , 283 , 284 , 285 , 356 , 381 , 549 , 550 , 551 , 552 , 553 , 554 , 634 , 635 , 636 , 638 , 712 , 714 , 717 , 724 , 734 , 839 , 840 , 843 , 844 , 965 ) , gastric carcinoma, surrounding tissue ( 368 , 444 , 632 , 633 , 637 , 639 , 647 , 649 , 711 , 713 ) , kidney cancer ( 462 , 463 ) , kidney cancer, surrounding tissue ( 465 , 467 , 485 ) , leukemia ( 85 , 86 , 87 , 88 , 92 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 251 , 257 , 258 , 259 , 260 , 263 , 264 , 265 , 266 , 347 , 348 , 385 , 386 , 387 , 388 , 389 , 391 , 396 , 397 , 399 , 400 , 416 , 417 , 420 , 421 , 428 , 429 , 431 , 452 , 453 , 454 , 455 , 460 , 461 , 477 , 478 , 479 , 480 , 514 , 515 , 573 , 574 , 580 , 581 , 582 , 583 , 705 , 706 , 707 , 708 , 709 , 715 , 763 , 765 , 766 , 767 , 768 , 769 , 770 , 774 , 775 , 776 , 780 , 813 , 814 , 815 , 816 , 820 , 821 , 826 , 827 , 841 , 842 , 846 , 848 , 849 , 850 , 852 , 869 , 889 , 890 , 892 , 902 , 906 , 907 , 908 , 909 , 918 , 928 , 929 , 969 , 975 , 976 , 980 , 981 , 982 , 983 , 984 , 988 , 990 , 994 , 995 , 996 , 997 , 1000 , 1001 , 1002 , 1003 , 1004 , 1005 , 1006 , 1032 , 1033 , 1034 , 1035 , 1052 , 1064 , 1067 , 1074 , 1096 , 1097 , 1098 , 1099 , 1113 , 1119 , 1125 , 1131 ) , acute lymphocytic leukemia ( 200 , 907 , 918 , 976 , 1005 , 1113 , 1125 , 1131 ) , acute myelogenous leukemia ( 200 , 780 , 820 , 821 , 826 , 827 , 869 , 902 , 906 , 908 , 909 , 928 , 929 , 975 , 994 , 995 , 996 , 997 , 1000 , 1006 , 1052 , 1064 , 1067 , 1074 , 1096 , 1097 , 1098 , 1099 ) , chronic myelogenous leukemia ( 85 , 86 , 87 , 88 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 251 , 257 , 258 , 259 , 260 , 263 , 264 , 265 , 266 , 347 , 348 , 385 , 386 , 387 , 388 , 389 , 391 , 396 , 397 , 399 , 400 , 416 , 417 , 420 , 421 , 428 , 429 , 431 , 452 , 453 , 454 , 455 , 460 , 461 , 477 , 478 , 479 , 480 , 514 , 515 , 573 , 574 , 580 , 581 , 582 , 583 , 705 , 706 , 707 , 708 , 709 , 715 , 765 , 766 , 767 , 768 , 769 , 770 , 774 , 775 , 776 , 813 , 814 , 815 , 816 , 841 , 842 , 846 , 848 , 849 , 850 , 852 , 889 , 890 , 892 , 980 , 981 , 982 , 983 , 984 , 988 , 990 , 1001 , 1002 , 1003 , 1004 , 1032 , 1033 , 1034 , 1035 , 1119 ) , T cell leukemia ( 92 ) , liver cancer ( 198 , 303 , 304 , 305 , 306 , 307 , 464 , 466 , 495 , 502 , 503 , 504 , 506 , 507 , 511 , 513 , 517 , 547 , 548 , 556 , 558 , 559 , 560 , 587 , 653 , 692 , 694 , 696 , 728 ) , liver adenocarcinoma ( 548 ) , cholangiocellular carcinoma ( 198 , 558 , 653 , 696 ) , hepatocellular carcinoma ( 495 , 502 , 503 , 504 , 506 , 507 , 511 , 513 , 517 , 556 , 559 , 560 , 692 , 694 , 728 ) , hepatocellular carcinoma, surrounding tissue ( 505 , 508 , 510 , 557 , 700 ) , liver cancer, surrounding tissue ( 509 , 695 ) , lung cancer ( 4 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 14 , 33 , 34 , 35 , 36 , 37 , 38 , 63 , 80 , 150 , 151 , 152 , 159 , 160 , 161 , 162 , 163 , 171 , 172 , 173 , 248 , 249 , 309 , 342 , 344 , 346 , 355 , 381 , 402 , 403 , 404 , 405 , 410 , 412 , 414 , 518 , 521 , 522 , 523 , 570 , 571 , 572 , 575 , 576 , 607 , 608 , 612 , 642 , 646 , 650 , 651 , 667 , 702 , 703 , 704 , 718 , 719 , 734 , 779 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 802 , 807 , 808 , 809 , 810 , 834 , 835 , 836 , 837 , 838 , 853 , 854 , 855 , 856 , 857 , 858 , 859 , 860 , 862 , 864 , 865 , 866 , 871 , 872 , 874 , 875 , 877 , 879 , 880 , 881 , 883 , 903 , 915 , 916 , 917 , 930 , 940 , 943 , 944 , 945 , 946 , 947 , 949 , 950 , 952 , 953 , 974 , 986 , 987 , 989 , 1012 , 1013 , 1017 , 1019 , 1020 , 1025 , 1026 , 1027 , 1030 , 1040 , 1044 , 1049 , 1050 , 1051 , 1053 , 1056 , 1057 , 1058 , 1059 , 1060 , 1061 , 1062 , 1068 , 1071 , 1072 , 1075 , 1076 , 1077 , 1078 , 1079 , 1080 , 1082 , 1085 , 1090 , 1091 , 1092 , 1094 , 1095 , 1102 , 1103 , 1104 , 1105 , 1110 , 1115 , 1116 , 1118 , 1121 , 1123 , 1124 , 1126 , 1128 , 1132 , 1133 , 1143 , 1144 ) , non-small cell lung cancer ( 6 , 7 , 8 , 9 , 11 , 12 , 14 , 16 , 21 , 23 , 24 , 33 , 34 , 35 , 36 , 37 , 38 , 63 , 80 , 150 , 151 , 152 , 159 , 160 , 161 , 162 , 163 , 171 , 172 , 173 , 248 , 249 , 309 , 402 , 403 , 404 , 405 , 410 , 412 , 414 , 570 , 571 , 572 , 607 , 608 , 612 , 642 , 646 , 650 , 651 , 667 , 702 , 703 , 704 , 718 , 719 , 734 , 779 , 794 , 795 , 796 , 800 , 801 , 802 , 807 , 808 , 809 , 810 , 834 , 835 , 836 , 837 , 838 , 853 , 854 , 855 , 856 , 857 , 858 , 860 , 862 , 864 , 871 , 872 , 881 , 903 , 915 , 916 , 917 , 930 , 947 , 949 , 950 , 952 , 953 , 974 , 986 , 987 , 989 , 1012 , 1013 , 1017 , 1019 , 1020 , 1026 , 1027 , 1040 , 1044 , 1049 , 1053 , 1056 , 1057 , 1058 , 1059 , 1060 , 1062 , 1068 , 1071 , 1072 , 1075 , 1076 , 1077 , 1078 , 1079 , 1080 , 1082 , 1085 , 1090 , 1094 , 1095 , 1102 , 1103 , 1104 , 1105 , 1110 , 1115 , 1116 , 1118 , 1123 , 1124 , 1126 , 1128 , 1132 , 1133 , 1143 , 1144 ) , non-small cell lung cancer, surrounding tissue ( 352 ) , non-small cell lung adenocarcinoma ( 4 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 14 , 16 , 63 , 150 , 151 , 152 , 161 , 162 , 163 , 171 , 172 , 173 , 248 , 249 , 309 , 381 , 402 , 403 , 404 , 405 , 410 , 412 , 414 , 570 , 571 , 572 , 612 , 650 , 651 , 702 , 703 , 704 , 734 , 800 , 801 , 802 , 808 , 809 , 810 , 836 , 837 , 838 , 879 , 880 , 883 , 943 , 944 , 945 , 946 , 1060 , 1078 , 1115 ) , non-small cell lung adenocarcinoma, surrounding tissue ( 406 , 407 , 408 , 409 , 411 , 413 , 415 ) , non-small cell large cell lung carcinoma ( 8 , 11 , 877 ) , non-small cell squamous cell lung carcinoma ( 10 , 24 , 381 , 518 , 521 , 522 , 523 , 575 , 576 , 1049 , 1068 ) , small-cell lung cancer ( 1030 , 1091 , 1092 ) , lung cancer, surrounding tissue ( 187 , 231 , 343 , 345 ) , lymphoma ( 899 , 970 , 971 , 972 , 1088 ) , anaplastic large cell lymphoma ( 1088 ) , Hodgkin's lymphoma ( 899 , 970 , 971 , 972 ) , neuroblastoma ( 2 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 245 , 246 , 601 , 602 , 603 , 604 , 676 , 886 , 887 , 888 , 895 , 933 , 934 , 935 , 973 , 1021 ) , oropharyngeal cancer ( 993 ) , squamous cell carcinoma of the oropharynx ( 993 ) , ovarian cancer ( 68 , 189 , 205 , 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 214 , 215 , 233 , 234 , 235 , 332 , 333 , 334 , 336 , 338 , 340 , 362 , 363 , 364 , 365 , 367 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 750 , 751 , 752 , 755 , 756 , 757 , 758 , 977 , 978 , 979 , 991 , 992 , 1041 ) , ovarian epithelial carcinoma ( 68 , 189 , 206 , 211 , 977 , 978 , 991 , 992 ) , pancreatic cancer ( 524 , 1117 , 1135 , 1146 , 1147 ) , pancreatic carcinoma ( 1135 ) , pancreatic cancer, surrounding tissue ( 525 ) , multiple myeloma ( 543 , 544 , 941 , 942 , 1011 ) , prostate cancer ( 1136 ) , salivary gland cancer ( 592 , 593 , 594 , 595 , 596 , 597 , 598 , 599 , 600 ) , melanoma skin cancer ( 398 , 569 , 584 , 585 , 586 , 588 , 674 , 675 ) , non-melanoma skin cancer ( 1140 , 1141 , 1142 ) , leiomyosarcoma ( 25 ) , rhabdomyosarcoma ( 25 ) , teratoma ( 351 ) , thymic carcinoma ( 179 , 180 ) , thyroid cancer, surrounding tissue ( 710 ) , ventricular tachycardia ( 181 , 182 , 190 )
Relevant cell line - cell type - tissue:
143.98.2 (bone cell) ( 773 ) , 143B (bone cell) ( 746 ) , 184A1 (epithelial) [HER2 (human), transfection] ( 905 ) , 184A1 (epithelial) ( 512 , 905 ) , 23132/87 (gastric) ( 965 ) , 293 (epithelial) [EFNB1 (human), transfection] ( 383 ) , 293 (epithelial) [EphB2 (human), transfection] ( 383 ) , 42-MG-BA (glial) ( 931 ) , 44-ZW-5409 (eye cell) ( 786 ) , 47-CD-3188 (glial) ( 783 ) , 56-DT-9110 (glial) ( 785 ) , 5637 (bladder cell) ( 913 ) , 703167 (pulmonary) ( 342 ) , 8-MG-BA (glial) ( 1018 ) , A172 (glial) ( 1007 , 1008 ) , A204 (muscle cell) ( 25 ) , A431 (epithelial) ( 1140 , 1141 , 1142 ) , A498 (renal) ( 925 ) , A549 (pulmonary) [LKB1 (human), no information] ( 703 ) , A549 (pulmonary) ( 7 , 21 , 309 , 702 , 797 , 798 , 799 ) , A673 (muscle cell) ( 25 ) , ACC-S (adenoidal) ( 620 , 622 ) , AGS (gastric) ( 968 ) , AZ-521 (gastric) ( 721 ) , BEAS-2B (epithelial) [LKB1 (human), no information] ( 563 , 564 ) , BEAS-2B (epithelial) ( 561 , 562 ) , BGC823 (gastric) ( 20 ) , bladder ( 293 ) , bone marrow ( 200 , 780 ) , breast ( 1 , 914 ) , BT-20 (breast cell) ( 791 , 792 ) , BT-474 (breast cell) ( 526 ) , BxPC-3 (pancreatic) ( 1146 , 1147 ) , Caki-2 (renal) ( 912 , 923 , 926 ) , Cal-12T (pulmonary) ( 14 ) , CAL-85-1 (breast cell) ( 910 , 951 ) , Calu-3 (pulmonary) ( 9 , 1061 , 1121 ) , cardiac-heart ( 190 ) , CAS-1 (glial) ( 885 ) , CCF-STTG1 (glial) ( 1038 ) , CHO-K1 (fibroblast) ( 225 ) , cholangiocyte-liver ( 558 , 696 ) , CHRF (megakaryocyte) ( 928 ) , CMK (megakaryoblast) ( 1099 ) , CMS (myeloid) ( 896 , 908 , 909 ) , COLO-680N (esophageal) ( 67 , 331 , 998 ) , colon ( 201 , 203 , 204 , 230 , 294 , 295 , 777 , 778 ) , DBTRG-05MG (glial) ( 1045 ) , Detroit562 (squamous) ( 993 ) , DK-MG (glial) ( 1016 ) , DLD1 (intestinal) ( 25 , 149 ) , DMS153 (pulmonary) ( 12 , 1029 ) , DMS53 (pulmonary) ( 1092 ) , DMS79 (pulmonary) ( 1091 ) , DV-90 (pulmonary) ( 940 ) , E.coli (bacterial) ( 782 ) , EFM-19 (breast cell) ( 922 ) , EFM-192A (breast cell) ( 937 ) , EFO-21 (ovarian) ( 979 ) , ES2 (ovarian) ( 977 ) , esophagus ( 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 ) , FU97 (gastric) ( 353 , 354 , 722 ) , GAMG (glial) ( 1022 , 1023 ) , GDM-1 (myeloid) ( 1074 ) , GI-CA-N (neural crest) ( 2 , 886 ) , GI-ME-N (neuron) ( 2 , 895 ) , glial-brain ( 19 ) , HCC1143 (breast cell) ( 1039 ) , HCC1395 (breast cell) ( 1031 ) , HCC15 (pulmonary) ( 10 ) , HCC1806 (breast cell) ( 1048 ) , HCC202 (breast cell) ( 787 , 788 ) , HCC366 (pulmonary) ( 1095 ) , HCC44 (pulmonary) ( 14 , 1080 ) , HCC70 (breast cell) ( 893 , 894 ) , HCC78 (pulmonary) ( 11 , 151 , 152 , 163 , 612 , 917 , 1079 ) , HCC827 (pulmonary) ( 9 , 248 , 249 , 309 , 734 , 800 , 801 , 802 , 836 , 837 , 838 , 1060 , 1115 ) , HCT116 (intestinal) ( 82 , 83 , 84 , 153 , 154 , 845 , 919 , 954 , 1111 , 1112 ) , HCT15 (intestinal) ( 999 ) , HD-MyZ (myeloid) ( 899 , 971 ) , HDLM-2 (lymphoid) ( 970 ) , HDQ-P1 (breast cell) ( 938 ) , heart ( 181 , 182 ) , HEL (erythroid) ( 929 , 996 , 997 , 1047 ) , HeLa (cervical) ( 5 , 17 , 357 , 358 , 591 , 655 , 668 , 669 , 670 , 671 ) , HeLa S3 (cervical) ( 380 ) , hepatic-'liver, para-hepatocellular carcinoma tissue' ( 505 , 508 , 510 , 557 , 700 ) , hepatocyte-liver ( 495 , 502 , 503 , 504 , 506 , 507 , 511 , 513 , 556 , 559 , 692 , 694 , 728 ) , HES-3 ('stem, embryonic') ( 199 ) , HLE (hepatic) ( 560 ) , HLF (hepatic) ( 517 ) , Hs746T (pancreatic) ( 901 ) , HT-29 (intestinal) ( 967 , 1073 , 1107 , 1108 , 1114 , 1137 , 1138 , 1139 ) , HU-3 (myeloid) ( 1096 ) , HuCCT1 (hepatic) ( 653 ) , HUVEC (endothelial) ( 624 , 625 , 626 , 627 , 628 , 629 , 630 ) , IM95 (gastric) ( 723 ) , J82 (bladder cell) ( 924 ) , JHH-4 (hepatic) ( 587 ) , JIMT-1 (breast cell) ( 911 , 948 ) , Jurkat (T lymphocyte) ( 26 , 30 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 89 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 105 , 106 , 107 , 108 , 109 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 148 , 168 , 169 , 170 , 174 , 175 , 176 , 177 , 178 , 183 , 184 , 185 , 186 , 202 , 216 , 226 , 227 , 228 , 229 , 232 , 236 , 237 , 239 , 240 , 241 , 242 , 244 , 253 , 254 , 255 , 256 , 267 , 268 , 269 , 270 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 286 , 287 , 288 , 289 , 290 , 291 , 296 , 297 , 298 , 299 , 300 , 301 , 302 , 308 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 318 , 319 , 320 , 321 , 322 , 335 , 337 , 339 , 341 , 349 , 359 , 360 , 361 , 382 , 384 , 390 , 392 , 393 , 394 , 418 , 419 , 430 , 432 , 433 , 434 , 435 , 447 , 448 , 449 , 450 , 451 , 456 , 457 , 458 , 459 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 481 , 482 , 483 , 484 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 496 , 497 , 498 , 499 , 500 , 501 , 516 , 519 , 520 , 528 , 529 , 545 , 546 , 555 , 566 , 567 , 568 , 577 , 578 , 579 , 605 , 606 , 609 , 610 , 611 , 616 , 631 , 640 , 641 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 672 , 673 , 677 , 678 , 679 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 689 , 690 , 691 , 693 , 697 , 698 , 699 , 701 , 726 , 727 , 732 , 733 , 735 , 736 , 737 , 738 , 739 , 747 , 748 , 749 , 753 , 781 , 793 , 803 , 804 , 805 , 806 , 811 , 812 , 819 , 863 , 867 , 868 , 936 , 955 , 956 , 957 , 958 , 959 , 960 , 961 , 962 , 1024 , 1043 , 1046 , 1054 , 1055 , 1063 , 1065 , 1066 , 1100 , 1101 , 1120 , 1127 , 1134 ) , Jurkat E6-1 (T lymphocyte) ( 18 ) , K562 (erythroid) ( 85 , 86 , 87 , 88 , 147 , 167 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 251 , 257 , 258 , 259 , 260 , 263 , 264 , 265 , 266 , 347 , 348 , 385 , 386 , 387 , 388 , 389 , 391 , 396 , 397 , 399 , 400 , 416 , 417 , 420 , 421 , 428 , 429 , 431 , 452 , 453 , 454 , 455 , 460 , 461 , 477 , 478 , 479 , 480 , 514 , 515 , 573 , 574 , 580 , 581 , 582 , 583 , 705 , 706 , 707 , 708 , 709 , 715 , 765 , 766 , 767 , 768 , 769 , 770 , 774 , 775 , 776 , 813 , 814 , 815 , 816 , 817 , 818 , 830 , 831 , 832 , 833 , 841 , 842 , 846 , 847 , 848 , 849 , 850 , 851 , 852 , 889 , 890 , 892 , 898 , 920 , 921 , 980 , 981 , 982 , 983 , 984 , 988 , 990 , 1001 , 1002 , 1003 , 1004 , 1032 , 1033 , 1034 , 1035 , 1036 , 1037 , 1119 ) , KATO III (gastric) ( 549 , 550 , 551 , 966 ) , KELLY (neural crest) ( 2 , 973 ) , KG-1 (myeloid) ( 869 ) , kidney ( 462 , 463 , 465 , 467 , 485 ) , Kit225 (T lymphocyte) ( 92 ) , KMS-11 (B lymphocyte) ( 395 , 942 ) , KPL-4 (breast cell) ( 13 ) , Kyse140 (esophageal) ( 328 , 904 , 1010 ) , Kyse150 (esophageal) ( 323 ) , Kyse180 (esophageal) ( 330 ) , Kyse270 (esophageal) ( 326 , 927 ) , Kyse410 (esophageal) ( 327 ) , Kyse510 (esophageal) ( 325 ) , Kyse520 (esophageal) ( 324 ) , Kyse70 (esophageal) ( 329 , 1009 ) , L428 (lymphoid) ( 972 ) , LAN-1 (neural crest) ( 2 , 887 ) , LAN-5 (neural crest) ( 2 , 888 ) , LAN-6 (neural crest) ( 2 , 219 , 221 , 601 , 602 , 603 , 604 ) , LCLC-103H (pulmonary) ( 949 ) , liver ( 198 , 303 , 304 , 305 , 306 , 307 , 464 , 466 , 509 , 695 ) , LN405 (glial) ( 932 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFR (wildtype)] ( 188 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFRvIII mutant (aka Delta EGFR, d2-7 EGFR; del. exon 2-7; in-frame loss 801 bp/267 aa in EC domain)] ( 188 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFRvIII-ki mutant (deletion of exons 2-7 plus kinase inactive mutation)] ( 188 ) , LN444 (glial) ( 422 , 423 , 424 , 425 , 426 , 427 ) , LOU-NH91 (squamous) ( 10 ) , lung ( 7 , 8 , 9 , 10 , 11 , 12 , 14 , 171 , 172 , 173 , 187 , 231 , 343 , 344 , 345 , 346 , 352 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 518 , 521 , 522 , 523 , 570 , 571 , 572 , 575 , 576 , 642 , 646 , 650 , 651 , 718 , 719 , 779 , 853 , 854 , 855 , 856 , 857 , 858 , 859 , 860 , 862 , 864 , 865 , 866 , 871 , 872 , 874 , 875 , 915 , 930 , 985 , 986 , 987 , 1017 , 1019 , 1020 , 1025 , 1044 , 1050 , 1051 , 1053 , 1071 , 1072 , 1081 , 1082 , 1083 , 1084 , 1085 , 1093 , 1094 , 1103 , 1104 , 1105 , 1106 ) , lymphoid-blood ( 1088 ) , M-07e (myeloid) ( 1097 ) , Marimo (myeloid) ( 200 ) , MCAS (ovarian) ( 215 ) , MCF-10A (breast cell) ( 1086 , 1087 , 1129 , 1130 ) , MDA-MB-361 (breast cell) ( 527 ) , MDA-MB-415 (breast cell) ( 789 , 790 ) , MDA-MB-453 (breast cell) ( 1089 ) , ME-F2 (myeloid) ( 200 , 1006 , 1067 ) , MG63 (bone cell) ( 25 , 745 ) , MHH-CALL4 (B lymphocyte) ( 976 ) , MHH-NB-11 (neural crest) ( 2 , 933 ) , MKN-1 (gastric) ( 724 ) , MKN-45 (gastric) ( 22 , 29 , 31 , 32 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 59 , 60 , 61 , 62 , 81 , 101 , 102 , 103 , 104 , 110 , 111 , 112 , 113 , 114 , 115 , 141 , 142 , 143 , 144 , 145 , 146 , 155 , 156 , 164 , 165 , 238 , 243 , 252 , 261 , 262 , 271 , 272 , 273 , 274 , 283 , 284 , 285 , 356 , 381 , 552 , 553 , 554 , 618 , 619 , 734 , 839 , 840 , 843 , 844 ) , MKN-7 (gastric) ( 729 ) , MKN-74 (gastric) ( 730 ) , MNNG-HOS (bone cell) ( 25 , 1122 ) , Molm 14 (myeloid) ( 902 , 1064 ) , MUTZ-5 (B lymphocyte) ( 907 ) , MV4-11 (macrophage) ( 824 , 825 , 826 , 827 , 828 , 829 , 906 ) , myeloid-bone marrow ( 975 , 1000 ) , NALM19 (B lymphocyte) ( 969 ) , NCCIT (epithelial) ( 351 ) , NCI-H1299 (pulmonary) ( 8 , 309 , 667 , 1056 ) , NCI-H1355 (pulmonary) ( 7 ) , NCI-H1373 (pulmonary) ( 1143 ) , NCI-H1435 (pulmonary) ( 1040 ) , NCI-H1437 (pulmonary) ( 12 , 14 , 1076 ) , NCI-H1568 (pulmonary) ( 1075 ) , NCI-H1648 (pulmonary) ( 1057 ) , NCI-H1650 (pulmonary) ( 9 , 33 , 34 , 35 , 36 , 37 , 38 , 159 , 160 , 734 , 1058 , 1126 , 1132 , 1145 ) , NCI-H1666 (pulmonary) ( 14 , 1124 , 1133 ) , NCI-H1703 (squamous) ( 10 , 24 , 381 , 530 , 531 , 532 , 613 , 794 , 795 , 796 , 1102 ) , NCI-H1734 (pulmonary) ( 8 , 734 , 1123 ) , NCI-H1781 (pulmonary) ( 11 , 903 ) , NCI-H1792 (pulmonary) ( 7 , 565 ) , NCI-H1838 (pulmonary) ( 1027 ) , NCI-H1869 (squamous) ( 1049 ) , NCI-H1944 (pulmonary) ( 8 , 1078 ) , NCI-H1975 (pulmonary) ( 9 , 309 , 734 , 1059 , 1128 ) , NCI-H1993 (pulmonary) ( 1118 ) , NCI-H2052 (pulmonary) ( 950 ) , NCI-H2066 (pulmonary) ( 1013 ) , NCI-H2073 (pulmonary) ( 10 , 12 , 953 ) , NCI-H209 (pulmonary) ( 12 ) , NCI-H2106 (pulmonary) ( 9 ) , NCI-H2126 (pulmonary) [LKB1 (human), no information] ( 704 ) , NCI-H2135 (pulmonary) ( 1012 ) , NCI-H2228 (pulmonary) ( 11 , 16 , 656 , 657 , 1090 ) , NCI-H2286 (pulmonary) ( 1030 ) , NCI-H23 (pulmonary) ( 7 ) , NCI-H2342 (pulmonary) ( 10 , 952 ) , NCI-H2347 (pulmonary) ( 1116 ) , NCI-H2405 (pulmonary) ( 14 ) , NCI-H2452 (pulmonary) ( 947 ) , NCI-H28 (pulmonary) ( 939 ) , NCI-H292 (pulmonary) ( 309 ) , NCI-H3122 (pulmonary) ( 11 , 150 , 161 , 162 ) , NCI-H3255 (pulmonary) ( 23 , 63 , 80 , 381 , 617 , 734 , 834 , 835 , 916 , 1062 , 1110 ) , NCI-H358 (pulmonary) [LKB1 (human), no information] ( 608 ) , NCI-H358 (pulmonary) ( 8 , 309 , 607 ) , NCI-H441 (pulmonary) ( 7 , 309 , 1144 ) , NCI-H460 (pulmonary) ( 8 ) , NCI-H520 (squamous) ( 1068 ) , NCI-H596 (pulmonary) ( 974 , 989 , 1026 ) , NCI-H661 (pulmonary) ( 11 ) , NCI-H838 (pulmonary) ( 12 , 1077 ) , NCI-H929 (B lymphocyte) ( 543 ) , NOMO-1 (myeloid) ( 820 , 821 ) , NOZ ('epithelial, gallbladder') ( 614 ) , NT2 (testicular) ( 350 ) , NUGC-3 (gastric) ( 725 ) , OCI/AML2 (myeloid) ( 1052 ) , OCI/AML3 (myeloid) ( 200 , 994 , 995 ) , OCUG-1 ( 654 ) , OCUM-1 (gastric) ( 720 ) , OPM-1 (B lymphocyte) ( 941 ) , OV90 (ovarian) ( 978 ) , ovary ( 332 , 333 , 334 , 336 , 338 , 340 , 362 , 363 , 364 , 365 , 367 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 750 , 751 , 752 , 755 , 756 , 757 , 758 ) , OVISE (ovarian) ( 214 ) , OVKATE (ovarian) ( 205 , 207 ) , OVMANA (ovarian) ( 68 , 189 , 206 , 211 ) , OVMIU (ovarian) ( 209 ) , OVSAHO (ovarian) ( 208 , 234 ) , OZ (bile-duct cell) [RAIG1 (human), knockdown] ( 69 , 70 ) , OZ (bile-duct cell) ( 71 , 615 ) , P116 (T lymphocyte) [ZAP70 (human), homozygous knockout] ( 401 ) , pancreas ( 524 , 525 , 1117 ) , PC3 (prostate cell) ( 1136 ) , PC9 (pulmonary) ( 6 , 309 , 807 , 808 , 809 , 810 , 881 ) , PC9-IR (pulmonary) ( 4 , 6 , 879 , 880 , 943 , 944 ) , PC9-TAR (pulmonary) ( 883 , 945 , 946 ) , RD18 (muscle cell) ( 25 ) , RKO (intestinal) ( 1042 ) , RMG1 (ovarian) ( 213 , 235 ) , RMUG-S (ovarian) ( 212 ) , SACC-83 (salivary gland) ( 621 , 623 ) , salivary gland ( 592 , 593 , 594 , 595 , 596 , 597 , 598 , 599 , 600 ) , Saos-2 (bone cell) ( 25 ) , SCH (gastric) ( 731 ) , SEM (B lymphocyte) ( 200 , 918 , 1005 , 1113 , 1125 , 1131 ) , SH-SY5Y (neural crest) ( 2 , 217 , 218 , 245 , 246 ) , SJSA-1 (bone cell) ( 771 ) , SK-HEP-1 (endothelial) ( 548 ) , SK-LMS-1 (muscle cell) ( 25 ) , SK-N-BE(2) (neural crest) ( 2 , 222 , 223 , 224 ) , skin ( 292 , 398 , 569 , 584 , 585 , 586 , 588 , 674 , 675 ) , SKNDZ (neural crest) ( 2 , 934 ) , SKNFI (neural crest) ( 2 , 935 ) , SKNSH (neural crest) ( 2 , 1021 ) , SKOV-3 (ovarian) ( 991 ) , SMS-KCN (neural crest) ( 2 , 676 ) , SMS-KCN-A (neural crest) ( 2 , 220 ) , SNU-1 (gastric) ( 963 ) , SNU-16 (gastric) ( 964 ) , SNU-308 (bile-duct cell) ( 589 ) , SNU-449 (hepatic) ( 547 ) , SNU-478 (bile-duct cell) ( 590 ) , SNU-5 (gastric) ( 900 ) , stomach ( 366 , 368 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 632 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 643 , 644 , 645 , 647 , 648 , 649 , 711 , 712 , 713 , 714 , 716 , 717 ) , Su.86.86 (pancreatic) ( 1135 ) , SW1710 (bladder cell) ( 878 ) , SW1783 (glial) ( 1028 ) , SW480 (intestinal) ( 20 , 740 , 741 , 742 , 743 , 891 , 1069 ) , SW620 (intestinal) ( 861 , 1014 , 1015 , 1070 ) , SW780 (bladder cell) ( 876 ) , T1-73 (bone cell) ( 772 ) , TERT20 ('stem, mesenchymal') ( 688 ) , thymus ( 179 , 180 ) , thyroid ( 710 ) , TOV21G (ovarian) ( 992 ) , TYK-nu (ovarian) ( 210 , 233 ) , U-118MG (glial) ( 157 , 158 , 166 , 652 , 1109 ) , U266 (plasma cell) ( 544 ) , U2OS (bone cell) ( 25 ) , UACC-812 (breast cell) ( 873 ) , UT-7 (myeloid) ( 1098 ) , VACO432 (ovarian) ( 1041 ) , XG7 (B lymphocyte) ( 1011 )

Upstream Regulation
Putative in vivo kinases:
Arg (human) ( 3 )
Kinases, in vitro:
Arg (human) ( 3 )
Putative upstream phosphatases:
PTP4A3 (human) ( 20 )
Treatments:
anti-CD28 ( 1024 ) , anti-CD3 ( 1024 ) , ephrin_B1 ( 383 ) , ephrin_B2 ( 383 ) , erlotinib ( 13 ) , gefitinib ( 381 ) , HGF ( 149 ) , P0108 ( 20 ) , Su11274 ( 381 ) , U0126 ( 18 )

Downstream Regulation
Effects of modification on ITGB1:
intracellular localization ( 782 ) , molecular association, regulation ( 782 )
Induce interaction with:
tensin 1 (human) ( 782 )

Disease / Diagnostics Relevance
Relevant diseases:
cholangiocellular carcinoma ( 198 )

References 

1

Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275   Curated Info

2

Palacios-Moreno J, et al. (2015) Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts. PLoS Comput Biol 11, e1004130
25884760   Curated Info

3

Simpson MA, et al. (2015) Direct interactions with the integrin β1 cytoplasmic tail activate the Abl2/Arg kinase. J Biol Chem 290, 8360-72
25694433   Curated Info

4

Tsai CF, et al. (2015) Large-scale determination of absolute phosphorylation stoichiometries in human cells by motif-targeting quantitative proteomics. Nat Commun 6, 6622
25814448   Curated Info

5

Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94
25159151   Curated Info

6

Yoshida T, et al. (2014) Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer. Clin Cancer Res 20, 4059-74
24919575   Curated Info

7

Rikova K, Hall B (2013) CST Curation Set: 20736, 21163, 30158, 30159, 30160; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

8

Rikova K, Hall B (2013) CST Curation Set: 20737, 21164, 30161, 30162, 30163; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

9

Rikova K, Hall B (2013) CST Curation Set: 20738, 21165, 30164, 30165, 30166; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

10

Rikova K, Hall B (2013) CST Curation Set: 20739, 21166, 30167, 30168, 30169; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

11

Rikova K, Hall B (2013) CST Curation Set: 20740, 21167, 30170, 30171, 30172; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

12

Rikova K, Hall B (2013) CST Curation Set: 20742, 21169, 30176, 30177, 30178; Year: 2013; Biosample/Treatment: cell line, H838, DMS153, H2073, H209, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

13

Tzouros M, et al. (2013) Development of a 5-plex SILAC method tuned for the quantitation of tyrosine phosphorylation dynamics. Mol Cell Proteomics 12, 3339-49
23882028   Curated Info

14

Rikova K, Hall B (2013) CST Curation Set: 20741, 21168, 30173, 30174, 30175; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

15

Shiromizu T, et al. (2013) Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res 12, 2414-21
23312004   Curated Info

16

Rikova K (2013) CST Curation Set: 18449; Year: 2012; Biosample/Treatment: cell line, H2228/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

17

Zhou H, et al. (2013) Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 12, 260-71
23186163   Curated Info

18

Helou YA, Nguyen V, Beik SP, Salomon AR (2013) ERK positive feedback regulates a widespread network of tyrosine phosphorylation sites across canonical T cell signaling and actin cytoskeletal proteins in Jurkat T cells. PLoS One 8, e69641
23874979   Curated Info

19

Johnson H, et al. (2012) Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts. Mol Cell Proteomics 11, 1724-40
22964225   Curated Info

20

Tian W, et al. (2012) Phosphatase of regenerating liver-3 directly interacts with integrin β1 and regulates its phosphorylation at tyrosine 783. BMC Biochem 13, 22
23092334   Curated Info

21

Rikova K (2012) CST Curation Set: 16140; Year: 2012; Biosample/Treatment: cell line, A549/iressa, gleevec, crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

22

Rikova K (2012) CST Curation Set: 16137; Year: 2012; Biosample/Treatment: cell line, MKN45/crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

23

Rikova K (2012) CST Curation Set: 16138; Year: 2012; Biosample/Treatment: cell line, H3255/iressa; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

24

Rikova K (2012) CST Curation Set: 16139; Year: 2012; Biosample/Treatment: cell line, H1703/gleevec; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

25

Bai Y, et al. (2012) Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res 72, 2501-11
22461510   Curated Info

26

Zhou J (2012) CST Curation Set: 14432; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

27

Rikova K (2012) CST Curation Set: 14270; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 1mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

28

Rikova K (2012) CST Curation Set: 14271; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 2mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

29

Mulhern D (2012) CST Curation Set: 14193; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

30

Zhou J (2012) CST Curation Set: 14185; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

31

Zhou J (2012) CST Curation Set: 14105; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

32

Zhou J (2012) CST Curation Set: 14107; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

33

Possemato A (2012) CST Curation Set: 14060; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

34

Possemato A (2012) CST Curation Set: 14061; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

35

Possemato A (2012) CST Curation Set: 14062; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

36

Possemato A (2012) CST Curation Set: 14063; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

37

Possemato A (2012) CST Curation Set: 14058; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

38

Possemato A (2012) CST Curation Set: 14059; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

39

Zhou J (2012) CST Curation Set: 14007; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

40

Zhou J (2012) CST Curation Set: 14008; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

41

Zhou J (2012) CST Curation Set: 14009; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

42

Zhou J (2012) CST Curation Set: 14010; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

43

Zhou J (2012) CST Curation Set: 13888; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

44

Zhou J (2012) CST Curation Set: 13889; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

45

Zhou J (2012) CST Curation Set: 13898; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

46

Zhou J (2012) CST Curation Set: 13899; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

47

Zhou J (2012) CST Curation Set: 13884; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

48

Zhou J (2012) CST Curation Set: 13885; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

49

Zhou J (2012) CST Curation Set: 13886; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

50

Zhou J (2012) CST Curation Set: 13887; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

51

Mulhern D (2012) CST Curation Set: 13932; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

52

Mulhern D (2012) CST Curation Set: 13933; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

53

Zhou J (2012) CST Curation Set: 13838; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

54

Zhou J (2012) CST Curation Set: 13839; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

55

Zhou J (2012) CST Curation Set: 13840; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

56

Zhou J (2012) CST Curation Set: 13841; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

57

Rikova K (2012) CST Curation Set: 13730; Year: 2012; Biosample/Treatment: cell line, Mix of TMT treated cell lines 2/treated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

58

Rikova K (2012) CST Curation Set: 13731; Year: 2012; Biosample/Treatment: cell line, Mix of TMT treated cell lines 3/treated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

59

Zhou J (2012) CST Curation Set: 13688; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

60

Zhou J (2012) CST Curation Set: 13689; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

61

Zhou J (2012) CST Curation Set: 13690; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

62

Zhou J (2012) CST Curation Set: 13691; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

63

Possemato A (2012) CST Curation Set: 13555; Year: 2012; Biosample/Treatment: cell line, NCI-H3255/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

64

Possemato A (2012) CST Curation Set: 13558; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

65

Possemato A (2012) CST Curation Set: 13559; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

66

Possemato A (2012) CST Curation Set: 13560; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

67

Tucker M (2012) CST Curation Set: 13497; Year: 2012; Biosample/Treatment: cell line, Colo-680N/untreated; Disease: esophageal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

68

Tucker M (2012) CST Curation Set: 13500; Year: 2012; Biosample/Treatment: cell line, OVMANA/untreated; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

69

Tucker M (2012) CST Curation Set: 13501; Year: 2012; Biosample/Treatment: cell line, OZ[RAIG1(knockdown)]/GPRC5A knockdown; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

70

Tucker M (2012) CST Curation Set: 13502; Year: 2012; Biosample/Treatment: cell line, OZ[RAIG1(knockdown)]/GPRC5A knockdown; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

71

Tucker M (2012) CST Curation Set: 13503; Year: 2012; Biosample/Treatment: cell line, OZ/untreated; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

72

Zhou J (2012) CST Curation Set: 12609; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

73

Zhou J (2012) CST Curation Set: 12610; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

74

Zhou J (2012) CST Curation Set: 12611; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

75

Zhou J (2012) CST Curation Set: 12612; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

76

Mulhern D (2012) CST Curation Set: 13337; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

77

Mulhern D (2012) CST Curation Set: 13338; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

78

Mulhern D (2012) CST Curation Set: 13335; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

79

Mulhern D (2012) CST Curation Set: 13336; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

80

Rikova K (2012) CST Curation Set: 13325; Year: 2012; Biosample/Treatment: cell line, NCI-H3255/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

81

Rikova K (2012) CST Curation Set: 13326; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

82

Mulhern D (2012) CST Curation Set: 13331; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

83

Mulhern D (2012) CST Curation Set: 13332; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

84

Mulhern D (2012) CST Curation Set: 13333; Year: 2012; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

85

Zhou J (2011) CST Curation Set: 12806; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

86

Zhou J (2011) CST Curation Set: 12808; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

87

Zhou J (2011) CST Curation Set: 12810; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

88

Mulhern D (2011) CST Curation Set: 13266; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

89

Mulhern D (2011) CST Curation Set: 13106; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

90

Rikova K (2011) CST Curation Set: 13117; Year: 2011; Biosample/Treatment: cell line, MGH-5/unknown; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

91

Rikova K (2011) CST Curation Set: 13122; Year: 2011; Biosample/Treatment: cell line, MGH-10/unknown; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

92

Osinalde N, et al. (2011) Interleukin-2 signaling pathway analysis by quantitative phosphoproteomics. J Proteomics 75, 177-91
21722762   Curated Info

93

Mulhern D (2011) CST Curation Set: 12687; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

94

Mulhern D (2011) CST Curation Set: 12689; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

95

Mulhern D (2011) CST Curation Set: 12691; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

96

Mulhern D (2011) CST Curation Set: 12693; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

97

Mulhern D (2011) CST Curation Set: 12695; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

98

Mulhern D (2011) CST Curation Set: 12697; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

99

Mulhern D (2011) CST Curation Set: 13031; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

100

Mulhern D (2011) CST Curation Set: 13033; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

101

Mulhern D (2011) CST Curation Set: 12645; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

102

Mulhern D (2011) CST Curation Set: 12853; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

103

Mulhern D (2011) CST Curation Set: 12854; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

104

Mulhern D (2011) CST Curation Set: 12855; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

105

Mulhern D (2011) CST Curation Set: 12643; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

106

Mulhern D (2011) CST Curation Set: 12644; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

107

Mulhern D (2011) CST Curation Set: 12578; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

108

Mulhern D (2011) CST Curation Set: 12579; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

109

Mulhern D (2011) CST Curation Set: 12582; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

110

Moritz A (2011) CST Curation Set: 12514; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

111

Moritz A (2011) CST Curation Set: 12515; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

112

Moritz A (2011) CST Curation Set: 12516; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

113

Moritz A (2011) CST Curation Set: 12517; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

114

Moritz A (2011) CST Curation Set: 12518; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

115

Moritz A (2011) CST Curation Set: 12519; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

116

Mulhern D (2011) CST Curation Set: 12471; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

117

Mulhern D (2011) CST Curation Set: 12472; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

118

Mulhern D (2011) CST Curation Set: 12473; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

119

Mulhern D (2011) CST Curation Set: 12475; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

120

Zhou J (2011) CST Curation Set: 12495; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

121

Zhou J (2011) CST Curation Set: 12496; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

122

Zhou J (2011) CST Curation Set: 12497; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

123

Zhou J (2011) CST Curation Set: 12344; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

124

Zhou J (2011) CST Curation Set: 12345; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

125

Zhou J (2011) CST Curation Set: 12346; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

126

Zhou J (2011) CST Curation Set: 12347; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

127

Zhou J (2011) CST Curation Set: 12348; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

128

Mulhern D (2011) CST Curation Set: 12401; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

129

Zhou J (2011) CST Curation Set: 12314; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

130

Zhou J (2011) CST Curation Set: 12316; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

131

Zhou J (2011) CST Curation Set: 12317; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

132

Zhou J (2011) CST Curation Set: 12318; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

133

Zhou J (2011) CST Curation Set: 12319; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

134

Zhou J (2011) CST Curation Set: 12320; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

135

Zhou J (2011) CST Curation Set: 12026; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

136

Zhou J (2011) CST Curation Set: 12029; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

137

Zhou J (2011) CST Curation Set: 12030; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

138

Zhou J (2011) CST Curation Set: 12031; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

139

Zhou J (2011) CST Curation Set: 12032; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

140

Zhou J (2011) CST Curation Set: 12033; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

141

Moritz A (2011) CST Curation Set: 12369; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

142

Moritz A (2011) CST Curation Set: 12370; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

143

Moritz A (2011) CST Curation Set: 12371; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

144

Moritz A (2011) CST Curation Set: 12372; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

145

Moritz A (2011) CST Curation Set: 12373; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

146

Moritz A (2011) CST Curation Set: 12374; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

147

Bergström Lind S, et al. (2011) Toward a comprehensive characterization of the phosphotyrosine proteome. Cell Signal 23, 1387-95
21447384   Curated Info

148

Moritz A (2011) CST Curation Set: 12258; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

149

Organ SL, et al. (2011) Quantitative Phospho-Proteomic Profiling of Hepatocyte Growth Factor (HGF)-MET Signaling in Colorectal Cancer. J Proteome Res 10, 3200-11
21609022   Curated Info

150

Possemato A (2011) CST Curation Set: 11908; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

151

Possemato A (2011) CST Curation Set: 11909; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

152

Possemato A (2011) CST Curation Set: 11910; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

153

Possemato A (2011) CST Curation Set: 11911; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

154

Possemato A (2011) CST Curation Set: 11912; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

155

Possemato A (2011) CST Curation Set: 11913; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

156

Possemato A (2011) CST Curation Set: 11914; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

157

Possemato A (2011) CST Curation Set: 11915; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

158

Possemato A (2011) CST Curation Set: 11916; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

159

Possemato A (2011) CST Curation Set: 11917; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

160

Possemato A (2011) CST Curation Set: 11918; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

161

Possemato A (2011) CST Curation Set: 11919; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

162

Possemato A (2011) CST Curation Set: 11920; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

163

Possemato A (2011) CST Curation Set: 11921; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

164

Possemato A (2011) CST Curation Set: 11925; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

165

Possemato A (2011) CST Curation Set: 11926; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

166

Possemato A (2011) CST Curation Set: 11927; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

167

Artemenko KA, et al. (2011) Optimization of immunoaffinity enrichment and detection: toward a comprehensive characterization of the phosphotyrosine proteome of K562 cells by liquid chromatography-mass spectrometry. Analyst 136, 1971-8
21403953   Curated Info

168

Guo A (2011) CST Curation Set: 11646; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

169

Guo A (2011) CST Curation Set: 11647; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

170

Guo A (2011) CST Curation Set: 11648; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991